Blocking CCL25 or CCR9 may represent a strange new safety therapy for RA, and provide theoretical basis for further research a novel safe therapy for RA (Yokoyama et al., 2014; Table 2). The gene discussed is CCL25; the disease is rheumatoid arthritis.